home-icon/Home / Investor relations / Calendar

Calendar of events

A close-up image of financial documents on a desk, featuring a calculator, a calendar from 2011, and graphs. The scene is arranged in a professional setting, suggesting work related to finance or accounting.
March 16, 2026 annual report for 2025
May 25, 2026 report for the first quarter of 2026
September 25, 2026 semi-annual report for the first half of 2026
November 27, 2026 report for the third quarter of 2026

 

The Company will not publish:

  • quarterly report for Q4 2026
  • quarterly report for Q2 2026

 

Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (MAR regulation) introduces the concept of the so-called closed periods for persons discharging managerial responsibilities within an issuer, for whom a prohibition was imposed to conduct any transactions on its own account or for the account of a third party, directly or indirectly, relating to the issuer’s shares or debt instruments, or derivative or other instruments related to financial instruments, during a closed period – 30 calendar days before the issuer’s publication of periodic financial reports (Article 19 paragraph 11 of MAR).

 

Closed periods:

  • February 14 – March 16, 2026 – closed period related to the publication of the annual report for 2025.
  • April 25 – May 25, 2026 – closed period related to the publication of the Q1 2026 report.
  • August 26 – September 25, 2026 – closed period related to the publication of the half-year report for the first half of 2026.
  • October 28 – November 27, 2026 – closed period related to the publication of the Q3 2026 report.

 

Closed periods are valid until the publication of the periodic report.

 

In accordance with the MAR regulation, all persons who have access to inside information before its publication, it is forbidden in particular:

  • to use inside information (insider dealing),
  • to disclosure unlawfully of inside information to unauthorized persons and entities,
  • to recommend or induce another person to acquire or dispose of financial instruments,
  • to conduct any transactions relating to the issuer’s shares or other instruments related to financial instruments, attempt to perform such transactions, as well as modify or cancel orders after acquired inside information.